Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Bausch Health Companies Inc (NYSE: BHC) was $6.78 for the day, up 0.59% from the previous closing price of $6.74. In other words, the price has increased by $0.59 from its previous closing price. On the day, 1.53 million shares were traded. BHC stock price reached its highest trading level at $6.995 during the session, while it also had its lowest trading level at $6.72.
Ratios:
Our analysis of BHC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 08 ’25 when Carson Seana sold 13,370 shares for $7.31 per share. The transaction valued at 97,735 led to the insider holds 499,585 shares of the business.
Carson Seana bought 13,370 shares of BHC for $97,735 on Sep 08 ’25. On Aug 21 ’25, another insider, Lee Frank D., who serves as the Director of the company, sold 15,912 shares for $7.66 each. As a result, the insider received 121,886 and left with 73,795 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2512104960 and an Enterprise Value of 23167105024. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.99, and their Forward P/E ratio for the next fiscal year is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 2.31 whereas that against EBITDA is 7.05.
Stock Price History:
The Beta on a monthly basis for BHC is 0.40, which has changed by -0.28450108 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.82, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is 1.68%, while the 200-Day Moving Average is calculated to be 7.59%.
Shares Statistics:
BHC traded an average of 2.84M shares per day over the past three months and 3291110 shares per day over the past ten days. A total of 370.47M shares are outstanding, with a floating share count of 327.99M. Insiders hold about 11.48% of the company’s shares, while institutions hold 66.64% stake in the company. Shares short for BHC as of 1760486400 were 7464358 with a Short Ratio of 2.62, compared to 1757894400 on 7927363. Therefore, it implies a Short% of Shares Outstanding of 7464358 and a Short% of Float of 2.18.
Earnings Estimates
The market rating of Bausch Health Companies Inc (BHC) is currently shaped by the ongoing analysis conducted by 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.77, with high estimates of $0.84 and low estimates of $0.65.
Analysts are recommending an EPS of between $4.01 and $3.72 for the fiscal current year, implying an average EPS of $3.89. EPS for the following year is $4.16, with 5.0 analysts recommending between $4.66 and $3.72.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 6 analysts. It ranges from a high estimate of $2.76B to a low estimate of $2.68B. As of. The current estimate, Bausch Health Companies Inc’s year-ago sales were $2.56BFor the next quarter, 6 analysts are estimating revenue of $2.42B. There is a high estimate of $2.43B for the next quarter, whereas the lowest estimate is $2.41B.
A total of 6 analysts have provided revenue estimates for BHC’s current fiscal year. The highest revenue estimate was $10.23B, while the lowest revenue estimate was $10.15B, resulting in an average revenue estimate of $10.19B. In the same quarter a year ago, actual revenue was $9.62BBased on 6 analysts’ estimates, the company’s revenue will be $10.52B in the next fiscal year. The high estimate is $10.77B and the low estimate is $10.08B.
